ArticleAnnals of transplantation2026

Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy.

Shih-Chao Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.